Autoimmune polyendocrine syndrome type I (APS I) and idiopathic Addison's disease are both disorders with adrenal insufficiency but with differences in genetic background, clinical presentation, and extent of extraadrenal manifestations. In this study the major adrenal autoantigen identified with sera from patients with APS I was characterized by analyses using indirect immunofluorescence, 
Introduction
Autoimmune polyendocrine syndrome type I (APS I),' Blizzard's syndrome, is a rare disorder with an autosomal recessive pattern of inheritance ( 1) . Apart from adrenal insufficiency, the endocrine features of the syndrome include hypoparathyroidism, gonadal insufficiency, and less frequently insulin-dependent diabetes mellitus (2) (3) (4) . Nonendocrine manifestations such as chronic mucocutaneous candidiasis (5), chronic active hepatitis, alopecia, and vitiligo also form part of the syn-f3-D-thiogalactoside; LH, luteinizing hormone; SSC, side chain cleavage enzyme.
drome (2) . The patients with APS I often display immunological abnormalities such as hypergammaglobulinemia, selective IgA deficiency, and defective T cell function (6) . In idiopathic Addison's disease, the autoimmune adrenalitis may occur isolated, although thyroiditis, diabetes mellitus, and vitiligo often are associated disorders. We have recently found that the major autoantigen in idiopathic Addison's disease is 2 1-hydroxylase (7) , an enzyme involved in the biosynthesis of cortisol and only expressed in the adrenal cortex. The clinical course of the adrenal insufficiency in APS I is different from that in Addison's disease, with an onset of symptoms during the first or second decade of life (4) . Furthermore, the disorders differ with respect to genetic markers, in that APS I shows a weak linkage to HLA A28 (8) , whereas idiopathic Addison's disease seems to be associated with HLA B8 (9) and HLA DR3 (10) . The fact that the two forms ofadrenalitis present such different features prompted us to examine the humoral immune responses to the adrenal gland.
Methods
Patients. Sera were obtained from five patients with APS I. Their ages range was 5-19 yr and the follow-up period spanned 4-1 1 yr. Mucocutaneous candidiasis was the first sign ofdisease in all the patients. Clinical signs of adrenal insufficiency developed at an average age of 5.2 yr (range, 1.5-10) , and all the patients were subsequently given hydrocortisone acetate replacement therapy. Patients 4 and 5 were also being treated with prednisolone and azathioprine therapy for chronic active hepatitis. Patients 1 and 2 were under treatment with 1,25-dihydroxycholecalciferol for hypoparathyroidism. Patient 1 also showed signs of gonadal insufficiency, with incomplete pubertal development and raised levels of follicle-stimulating hormone (FSH) and luteinizing hormone (LH). Two ofthe patients (nos. 1 and 5) were siblings. These two patients and patient 4 were all of Finnish origin. Patient 3 had had a younger sister who died when 5 yr old with a clinical picture of increased intracranial pressure and liver failure after chronic active hepatitis ( 11). Patient 4 had had an older sister who died when 5 yr old of hypocalcemic and/or Addison crises, likewise retrospectively assessed as a component of APS I. The patients also suffered from additional manifestations such as alopecia, vitiligo, and malabsorption (Table I) to varying degrees. Sera were also obtained from 15 patients (aged 19-77 yr) with idiopathic Addison's disease. All these sera identified 21-hydroxylase as the major adrenal autoantigen in Western blots using bovine adrenal homogenates (7). Sera from 15 healthy blood donors were used as controls. The serum cholesterol levels in the patients and controls all fell within the normal range and the means did not differ between the groups. Antibodies. A polyclonal antiserum was raised against bacterially expressed human cytochrome P450 side chain cleavage enzyme (SCC) produced in Escherichia coli by the pET-SCC vector, a generous gift from Dr. B. C. Chung (Institute of Molecular Biology, Academia, Taipei, Taiwan). Rabbit sera raised against bovine 1 lB-hydroxylase, bovine cytochrome P450 SCC, and porcine 17a-hydroxylase were purchased from Oxygen (Dallas, TX). A rabbit serum raised against 21 were blocked with gelatin (Bio-Rad Laboratories) and incubated for 2 h with patient sera that had been diluted to 1:100. Prestained standards (Bio-Rad Laboratories) were included in all the strips to secure correct alignment. Proteins were detected by incubation for 1.5 h with alkaline phosphatase-conjugated species-specific anti-IgG antibodies, followed by the p-nitro blue tetrazolium chloride/s-bromo-4-chloro-3-indoyl phosphate p-toluidine salt color development system as recommended (Bio-Rad Laboratories) (7).
Immunoprecipitation. A human adrenocortical cell line, NCI-H295 (American Type Culture Collection, Rockville, MD), was grown in hydrocortisone insulin transferrin 17#-estradiol and sodium selenite medium ( 14) . Cells were washed twice with the methioninefree RPMI 1640, incubated with 0.75 mCi 35S-methionine (Amersham International, Amersham, UK) for 12 h, harvested with a rubber policeman, washed twice, and then lysed on ice for 1 h in a 20 mM Tris-HCI buffer, pH 8.0, containing 150 mM NaCl, 0.01% NaN3, 1 mM PMSF, 1% Triton X-100, and 1% aprotinin (Trasylol; Bayer, Leverkusen, Germany). The lysate was centrifuged at 100,000 g for 30 min to remove debris. The radioactivity of the supernatant was determined and 10 X 106 cpm were used for each immunoprecipitation. The lysates were precleared overnight at +4°C with serum from a healthy blood donor. They were then incubated for 20 min with five times the volume of a 20% suspension of Staphyloccocus aureus Cowan strain 1 (a kind gift from Professor L. Rask, Swedish University ofAgricultural Sciences, Uppsala, Sweden) and spun for 3 min to reduce unspecific background. Aliquots of the precleared lysates were then again incubated overnight at +4°C in the prescence ofeither patient sera or polyclonal rabbit antisera. After adding S. aureus and collecting the precipitate the bacterial pellets were washed six times with a 0.2% Triton X-100 containing Tris-HCl buffer with or without 0.5 M NaCl, in three cycles. The final wash was carried out with redistilled water and the pellets were then heated in sample buffer ( 15) . The supernatants were subjected to SDS-PAGE. Gels were fixed in methanol/acetic acid and incubated for 30 min in Amplify (Amersham International). Fluorography was carried out at -70°C on dried gels.
Assay for enzymatic activity. Bovine adrenal gland homogenates were prepared in 0.25 M sucrose with 10 mM Tris-HCl buffer, pH 7.0, and 1 mM EDTA. The mitochondrial fraction was obtained by stepwise centrifugations, once at 800 g and twice at 8,500 g (16) . The mitochondrial pellet was suspended in 10 mM Tris-HCI, pH 7.0. 2 mg of mitochondrial protein in 10 mM Tris-HCl, pH 7.0, was incubated with 6 jg of [4- 
Results
Immunofluorescence. When human and rat adrenal glands were stained with sera from patients with APS I and from those with idiopathic Addison's disease, a pattern restricted to the cortex was observed with all sera. The strongest cytoplasmatic intensity was noted in the outermost layer, i.e., the zona glomerulosa (Fig. 1, A and B Fig. 2 , which shows a Western blot with a typical APS I serum, a serum taken from an adult patient with idiopathic Addison's disease, and different antisera raised against cytochrome P450 enzymes in adrenal steroid biosynthesis. It can be seen that the mobilities of the various enzymes were readily resolved in the system used. The serum from the patient with Addison's disease identified a protein that comigrated with the known autoantigen (Fig. 2, lanes D and E) , the 21-hydroxylase (7). In the same system, the serum from the APS I patient detected a 53-kD protein that comigrated with the cytochrome P450 cholesterol SCC (Fig. 2, lanes A and B) . None of the sera from the 15 patients with idiopathic Addison's disease identified this 53-kD band (not shown) and no bands in this molecular mass region were observed when sera from 15 healthy blood donors were tested. The 17a-hydroxylase and the 1 lb-hydroxylase enzymes were identified with specific rabbit antisera and these enzymes did not comigrate either with the protein recognized by the APS I sera or with that detected by the sera of patients with idiopathic Addison's disease. All the APS I sera also identified bacterially expressed SCC ( 12) in Western blots (Fig. 3) . The serum ofpatient 5 reacted weakly, as in the case ofthe previous Western blot experiment using the adrenal mitochondrial fraction. The bacterially expressed SCC was not identified by the sera of healthy blood donors or by those of patients with idiopathic Addison's disease. When Western blots of bacterially expressed 17a-hydroxylase were performed, four ofthe patient sera were negative and one patient serum (No. 2) showed a minor reactivity to 1 7a-hydroxylase. This appeared when the development time for the nitrocellulose strips was prolonged to 2 h (Fig. 4, lane D) , which contrasts with the strong reactivity of the APS I sera directed towards bacterially expressed SCC, which was detectable after 10 min (Fig. 4, lanes A and B) .
Immunoprecipitation. In immunoprecipitations of lysates of [35S]methionine labeled NCI-H295 cells, the sera from five APS I patients precipitated a protein that comigrated with the protein identified by a specific rabbit anti-SCC serum (exemplified in Fig. 5 ). After preclearance with specific SCC antibodies, the 53-kD reactivity disappeared completely on subsequent immunoprecipitation with sera from APS I patients. When the preclearance was carried out with the sera from healthy blood donors, a 53-kD band was clearly visible after subsequent immunoprecipitation with APS I sera (exemplified in Fig. 5 , lane D). Inhibition of enzyme activity. The sera of all five APS I patients were tested in an enzyme assay using adrenal mitochondria and were found to markedly inhibit the conversion of cholesterol to pregnenolone, a reaction catalyzed by the side chain cleavage enzyme. The mean reduction in the enzyme activity was 84% (range, 78-92%) (Table II) as compared with that produced by the sera of six healthy blood donors. In a separate experiment, the serum from patient 1 was compared with a control serum at different dilutions and displayed a dose-dependent inhibition of the SCC activity (Fig. 6) .
21-hydroxylase. No reactivity directed towards 21 -hydroxylase was observed with the five APS I sera investigated by Western blot analysis or in the immunoprecipitations ofthe labeled adrenocortical cell line NCI-H295 (Figs. 2 and 5) (7). The five sera also failed to identify the 2 1-hydroxylase when immunoprecipitations of [35S methionine-labeled lysates ofCHO cells, stably transformed with the human 2 1-hydroxylase cDNA (22) , were performed (not shown), whereas the sera of all patients with idiopathic Addison's disease identified this enzyme as previously shown (7). As mentioned above (Fig. 2, lane F) , the Addison sera displayed no reactivity towards SCC when tested against a large amount ofbacterially expressed SCC in a sensitive Western blot analysis.
Discussion
In this study we have identified the major adrenal autoantigen of patients with APS I as the cytochrome P450 cholesterol side chain cleavage enzyme. All the five tested sera from APS I patients identified SCC as the autoantigen in Western blots of bovine adrenal mitochondrial fractions, in Western blots of bacterially expressed SCC, and in immunoprecipitations ofthe radio-labeled human adrenocortical cell line NCI-H295. The sera stained all cell layers in the cortex with a preference for the outermost layer (zona glomerulosa) of the adrenal cortex as well as the Leydig cells of the testes, both tissues known to be rich in SCC. Furthermore, all five sera inhibited the mitochondrial conversion of cholesterol to pregnenolone, the reaction catalyzed by the side chain cleavage enzyme. A weaker reactivity at immunoblotting was observed with the serum of patient 5, which might have been due to the immunosuppressive therapy given to this patient. Another possible explanation is that the antibodies present in this serum may have been directed towards epitopes sensitive to conformational changes occurring during the Western blot procedure. The fact that the antibody titers as reflected in the immunofluorescence with sections ofadrenal glands or testes were equal to those observed in the other four sera favors the latter interpretation. The serum of patient 5 also markedly inhibited SCC activity.
The cholesterol side chain cleavage enzyme is a mitochondrial enzyme that is rate limiting in adrenal steroid biosynthesis. It has been cloned (23) and the gene is located on chromosome 15. The calculated molecular mass of 54 kD (24) is very close to the apparent migration of53 kD observed in our experimental system. Like many of the enzymes involved in adrenal steroid biosynthesis, SCC is a cytochrome P450 protein con- taining a prosthetic heme group. The enzymatic activity also requires adrenodoxin, adrenodoxin reductase, and NADPH (25) . A genetic defect of this enzyme causes a rare form of congenital adrenal hyperplasia, lipid storage disease, characterized by an excessive intraadrenal accumulation of cholesterol.
Krohn et al. (26) recently reported 1 7a-hydroxylase to be the adrenal autoantigen in APS I as assessed from the screening of a human fetal adrenal cDNA Xgt 11 library with serum pooled from one APS I patient and followed by sequencing of positive clones. The authors also found reactivity towards bacterially expressed enzyme in Western blot analysis (26) . In contrast, we did not detect any reactivity directed towards the 1 7a-hydroxylase with APS I sera in Western blots, using adrenal mitochondrial and microsomal (not shown) fractions ( 2). When 17a-hydroxylase produced by bacterial expression was used, one APS I serum showed slight reactivity, whereas the other four sera were negative (Fig. 4) . The patient serum that reacted weakly in this test with the 17a-hydroxylase displayed much stronger reactivity towards the bacterially produced SCC and did not react with 17a-hydroxylase but only with SCC in lysates from a [35S ] methionine-labeled adrenocortical cell line. With indirect immunofluorescence, the APS I sera in the present study identified the zona glomerulosa, a cell layer that does not display any 17a-hydroxylase activity (27, 28) , or immunoreactivity (29) . Furthermore, the APS I sera also stained the rat adrenal cortex, which is known to lack 17a-hydroxylase (28). Thus, our data strongly indicate that SCC is the major adrenal autoantigen identified by sera of patients with APS I. It is possible that when antigen produced by prokaryotic expression is used, a reactivity against 17a-hydroxylase may occur. If so, this could represent cross-reactivity, although the overall amino acid sequence homology between SCC and 17a-hydroxylase is only 16%. However, at the heme binding site, 7 of 12 amino acids are identical. In autoimmune adrenalitis the adrenal autoantigen seems to be well conserved between species (30), i.e., the epitope recognized by patient sera are presumably ofgreat importance, a finding consistent with our results demonstrating an inhibi- Preclearance with a serum from a normal blood donor followed by preclearance with a specific rabbit antiserum against the SSC and then immunoprecipitation with serum from APS I tion of the cholesterol side chain cleavage activity in the presence of sera from patients with APS I. Both linear and presumably nonlinear epitopes were recognized by APS I sera, i.e., the sera identified SCC in Western blots ofadrenal fractions and of bacterially expressed proteins containing linear epitopes. The sera precipitated SCC and inhibited the enzymatic reactivity indicating reactivity towards native epitopes. These findings are consitent with earlier reports concerning autoimmune hepatitis type II where the cytochrome P450 dbI is the target of the autoantibodies. These autoantibodies inhibit the enzymatic activity ofthe cytochrome P450 dbl and recognize linear epitopes of this enzyme in Western blots ( 31 ) . In contrast, monoclonal antibodies and polyclonal sera, recognizing differences between antigens, react towards nonconserved epitopes usually not involved in specific functions of the proteins.
We have recently shown that 2 1-hydroxylase is the major autoantigen in idiopathic Addison's disease of adult onset (7), and this finding has since been confirmed (32 Today, the distinction between autoimmune adrenalitis in APS I and that in idiopathic Addison's disease is based on the age of onset and extraadrenal manifestations (2) . In children who develop adrenalitis preceded by mucocutaneous candidiasis and hypoparathyroidism, the diagnosis is not difficult. However, when adrenalitis is the only presenting symptom in a young patient, it may be difficult to decide whether it is an isolated adrenalitis or an adrenalitis associated with the more serious APS I. Patients with APS I may develop additional symptoms as they grow older (4) , and have to be monitored because of the risk of developing hypocalcemia, malabsorption, chronic active hepatitis, and gonadal insufficiency. We are currently developing convenient autoantibody assays based on recombinant expression of the two autoantigens.
The adrenal autoantigens associated with APS I and idiopathic Addison's disease are intracellular enzymes, as in the case ofseveral other autoimmune diseases, such as thyroid peroxidase in autoimmune thyroiditis (33) , H+K+-ATPase in autoimmune gastritis (34) , and glutamate decarboxylase in diabetes mellitus (35) . The predilection for enzymes as autoantigens in autoimmune diseases (36, 37) is intriguing. The inhibition of SCC activity shown ( Fig. 6 and Table II) implies that some autoantibody epitopes are present near the catalytic and/or substrate-binding sites of the enzyme. This suggests that the humoral immune response is directed towards conserved parts ofthe enzyme and may favor the idea that certain amino acid sequences, evolutionary preserved for the maintenance ofenzymatic activity, are ofimportance in provoking an autoimmune response (7) . It could be argued that the production ofautoantibodies to the enzymes merely reflects an unspecific discharge of intracellular proteins after a primary cellular attack on the target organ. However, the results obtained in the present study illustrate a selectivity in the pathogenetic events, since no reactivity towards 2 1-hydroxylase could be detected in APS I sera, and, likewise, no reactivity towards SCC was observed in any of the sera from the patients with Addison's disease, even though a highly sensitive technique with recombinantly produced proteins was used. Thus, autoantibody production during the course of autoimmune adrenalitis may not merely represent secondary events but rather result from very specific immune processes.
